The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores opportunities for new investors and segregates Malaysia into potential, growing and nascent market, after taking into consideration past investment, policies, trends of new investment and other growth factors (socio-economy, technology, etc). The study will give insights to investors who plan to enter the Malaysian market, as well as help the existing manufacturers to look understand the competition.
Methodology and Scope This research service focuses on the Malaysian healthcare industry, providing a detailed overview of the investment scenario in particular. A brief overview of the tendering process, incentives for investors, and the distributor network has also been included.
This study does broadly discuss the revenue or financial forecasting of the healthcare industry, but does not address the companies which are involved with R&D or services in details.
Company profiles of those companies that are currently or imminently prominent and or may be of interest for investors in Malaysia, have been included. The information contained in this research service was derived from published sources including the following—Government of Malaysia websites, healthcare companies’ websites, World Health Organization data, World Bank data, International Monetary Fund data and press releases, public sources, the internal data bank of Frost & Sullivan, and industry key opinion leaders (KOLs). Primary and secondary research methodologies were used to gather and analyze the data, presented in this study.
Research Scope and Objectives The aim of this research service is to assess, analyse, and evaluate the healthcare industry in Malaysia and to provide strategic recommendations for new investors entering the market and for already existing investors to sustain their market share
Segment Scope The main objective of this research service is to establish an understanding of the key segments (healthcare services, connected health, medical devices, pharmaceuticals and biotechnology, and aged care), as well as to provide insights on competitors and investment pockets in Malaysia.
Methodology In-depth analysis of the Malaysian healthcare industry using primary research (manufacturers, hospitals, and clinics), secondary research, and Frost & Sullivan in-house data. The Frost & Sullivan forecasting model uses historical growth, drivers, and restraints to project the future market size. All figures are in US Dollars. The exchange rate used for any conversion is: $1 = MYR
Geographic Scope This research covers the overall healthcare industry in Malaysia.
Key Questions This Study Will Answer What does the Malaysian healthcare industry offer? What are the segments in healthcare which are growing? What are the three major concerns? What are the major drivers and restraints in the market? Why is Malaysia an investor’s destination? What are the strategic recommendations for an investor? What is the brand visibility of Malaysia as a healthcare industry? What is the value proposition for the investor? How is the competitive environment? Which are the major companies ruling the road?
Table Of Contents
Malaysia Healthcare Outlook 1. EXECUTIVE SUMMARY
Executive Summary Malaysia: An investor's DestinationâExecutive Summary CEO's Perspective Methodology and Scope Research Scope and Objectives Key Questions This Study Will Answer Key Companies to Watch Out For in 2015 Key Funding Agencies to Watch Out For in 2015 Game-Changing Strategies
2. MARKET OVERVIEW
Market Overview What Does The Healthcare Industry Offer? Will EPP be the Gateway for Investment? PESTLE AnalysisâConducive Business Setting: Better Transparency, Government Policies and Access to ASEAN
3. MARKET SEGMENTATION
Market Segmentation Malaysian Healthcare IndustryâMajor Segments Hospital Industry Overview IVD and POCT Industry Overview Connected Health Overview Medical Devices Industry Overview Pharmaceutical Industry Overview Biotechnology Industry Overview Aged Care Industry Overview SWOT Analysis
4. DRIVERS AND RESTRAINTS
Drivers and Restraints DriversâExplained RestraintsâExplained
5. FORECAST AND TRENDS IN MALAYSIAN HEALTHCARE INDUSTRY
Forecast and Trends in Malaysian Healthcare Industry Forecast Assumptions Demographic Indicators Market Engineering MeasurementsâSegments to Watch Out For Segment Life Cycle Analysis Key Segment Trends Revenue Forecast for Hospital Services Revenue Forecast for IVD and POCT Services Revenue Forecast for Connected Health Revenue Forecast for Medical Devices Revenue Forecast for Pharmaceuticals Revenue Forecast for Biotechnology Aged Care IndustryâGrowth Forecast*
6. COMPETITIVE PLAYBOOK
Competitive Playbook Competitive AnalysisâHospital Industry Competitive AnalysisâIVD and POCT Services Industry Connected Health Industry Medical Devices Industry Pharmaceutical Industry Biotechnology Industry Aged Care Industry
7. OPPORTUNITY IN THE HEALTHCARE INDUSTRY
Opportunity in the Healthcare Industry New Market OpportunityâHospitals New Market OpportunityâIVD and POCT New Market OpportunityâConnected Health New Market OpportunityâMedical Devices Industry New Market OpportunityâPharmaceutical and Biotechnology Industry New Market OpportunityâAged Care Industry Halal PlatformâKey Differentiators for Malaysia
8. STRATEGIC RECOMMENDATIONS
Strategic Recommendations Future of Malaysian Healthcare
9. THE LAST WORD
The Last Word Three Key Predictions Top 5 Segments of Malaysia's Growing Healthcare Industry Legal Disclaimer
10. APPENDIX 1: FOREIGN INVESTMENTS IN MALAYSIA
Appendix 1: Foreign Investments in Malaysia Acquisition of Real Estate/ Property by Foreign Parties Tax Incentives in Iskandar: for Approved Companies
11. APPENDIX 2: RULES AND REGULATIONS
Appendix 2: Rules and Regulations MalaysiaâGeneral Regulations Registration Process for a Medicinal Product Registration of Product Product Classification- Medicine Duration of Registration Pricing Regulation Restriction on Import of Foreign Drugs Regulations Related to Senior Living Services
12. THE FROST and SULLIVAN STORY
The Frost and Sullivan Story Value Proposition Global Perspective Industry Convergence 360Âº Research Perspective Implementation Excellence Our Blue Ocean Strategy